MFDS
- Marketing authorisation holder: GENENTECH INC
- Status: likely_approved
🇰🇷 Piasky in South Korea
Piasky (CROVALIMAB) regulatory status in South Korea.
Marketing authorisation
Piasky in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Piasky approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Piasky in South Korea?
GENENTECH INC holds the South Korean marketing authorisation.